Previous close | 12.14 |
Open | 12.14 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 12.14 - 12.14 |
52-week range | 9.05 - 12.14 |
Volume | |
Avg. volume | 544 |
Market cap | 18.239B |
Beta (5Y monthly) | 0.71 |
PE ratio (TTM) | 13.80 |
EPS (TTM) | 0.88 |
Earnings date | 15 Feb 2024 |
Forward dividend & yield | 0.40 (3.32%) |
Ex-dividend date | 06 Mar 2024 |
1y target est | N/A |
In the realm of employee benefits, the trend towards self‑funded healthcare is unmistakable, as the regulatory landscape continues to change and healthcare costs continue to escalate. The National Association of Insurance Commissioners estimates that approximately 90% of Fortune 500 companies have captive subsidiaries. To clarify this trend, QBE North America, a leader in the insurance sector, explains why captives are vital in healthcare strategies. Captives are specialized insurance subsidiari
Amidst a challenging day for the ASX200, which saw a decline of 1.1 percent across all sectors, and rising living costs impacting households, investors might find solace in dividend stocks that can offer potential income stability. In this context, exploring strong performers like Nick Scali among others becomes particularly relevant as they may provide a cushion against market volatility and economic pressures.
QBE North America today announced the launch of its Healthcare Liability practice, a suite of coverages designed to meet the unique needs of healthcare organizations. The practice, which consists of a dedicated team and core products, is part of QBE's longstanding commitment to help customers manage evolving risks and foster resilience.